Insider trading

Period: 120 months Stock: EXEL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

404 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

404 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

404 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

404 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
404 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
404 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

404 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2018
Garber Alan M Director
Sold, plan not stated
$109.52K 3,500 at 31.29
5.4%
28 Sep 2017
Schwab Gisela Pres Prod Dev & Med Aff & CMO
Sold, plan not stated
$791.35K 33,334 at 23.74
15.4%
28 Sep 2017
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$608.00K 25,000 at 24.32
8.5%
27 Sep 2017
Schwab Gisela Pres Prod Dev & Med Aff & CMO
Sold, plan not stated
$797.99K 33,333 at 23.94
15.4%
27 Sep 2017
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$55.02K 2,302 at 23.90
0.9%
26 Sep 2017
Schwab Gisela Pres Prod Dev & Med Aff & CMO
Sold, plan not stated
$789.33K 33,333 at 23.68
15.4%
22 Sep 2017
PAPADOPOULOS STELIOS Director · indirect
Sold, plan not stated
$254.00K 10,000 at 25.40
100%
Sold half or more
19 Sep 2017
Sold, plan not stated
$3.53M 127,790 at 27.63
11.0%
18 Sep 2017
Sold, plan not stated
$2.00M 72,210 at 27.76
5.9%
14 Sep 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.71M 100,000 at 27.08
62.5%
Sold half or more
14 Sep 2017
Haley Patrick J. Sr. Vice President, Commercial
Sold, plan not stated
$1.65M 60,640 at 27.21
59.3%
Sold half or more
13 Sep 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.70M 100,000 at 27.04
62.5%
Sold half or more
13 Sep 2017
WILLSEY LANCE Director
Sold, plan not stated
$1.35M 50,000 at 26.97
9.6%
12 Sep 2017
Senner Christopher J. EVP and CFO
Sold, plan not stated
$2.68M 100,000 at 26.79
49.3%
12 Sep 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.66M 100,000 at 26.59
62.5%
Sold half or more
12 Sep 2017
WILLSEY LANCE Director
Sold, plan not stated
$1.34M 50,000 at 26.79
8.8%
30 May 2017
Haley Patrick J. Sr. Vice President, Commercial
Sold, plan not stated
$92.30K 5,000 at 18.46
4.7%
15 May 2017
FELDBAUM CARL B Director
Sold, plan not stated 2×
$711.83K 32,988 at 21.58
48.7%
10 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.21M 100,000 at 22.07
62.5%
Sold half or more
9 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated 2×
$2.17M 100,000 at 21.69
62.5%
Sold half or more
8 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$246.45K 11,300 at 21.81
15.8%
5 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated 2×
$2.18M 100,000 at 21.85
62.5%
Sold half or more
4 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$1.31M 59,149 at 22.17
49.6%
3 May 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated 2×
$2.27M 100,000 at 22.67
62.5%
Sold half or more
1 May 2017
Schwab Gisela Pres Prod Dev & Med Aff & CMO
Sold, plan not stated 2×
$2.07M 89,910 at 23.01
34.5%
3 Apr 2017
Sold, plan not stated
$213.00K 10,000 at 21.30
7.7%
31 Mar 2017
Sold, plan not stated
$111.09K 5,150 at 21.57
6.6%
27 Mar 2017
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$144.70K 6,884 at 21.02
2.5%
22 Mar 2017
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$488.58K 23,787 at 20.54
7.9%
20 Mar 2017
FELDBAUM CARL B Director
Sold, plan not stated
$217.70K 10,000 at 21.77
17.0%
20 Mar 2017
Sold, plan not stated
$216.60K 10,000 at 21.66
0.8%
15 Mar 2017
Schwab Gisela Pres Prod Dev & Med Aff & CMO
Sold, plan not stated
$1.13M 50,007 at 22.53
24.0%
15 Mar 2017
WILLSEY LANCE Director
Sold, plan not stated
$228.60K 10,000 at 22.86
1.7%
13 Mar 2017
COHEN CHARLES Director
Sold, plan not stated
$218.20K 10,000 at 21.82
4.0%
10 Mar 2017
Sold, plan not stated
$879.20K 40,000 at 21.98
25.0%
6 Mar 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.26M 100,000 at 22.61
62.5%
Sold half or more
3 Mar 2017
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated 3×
$2.30M 100,000 at 23.04
28.9%
3 Mar 2017
MORRISSEY MICHAEL President and CEO
Sold, plan not stated
$2.28M 100,000 at 22.83
62.5%
Sold half or more
3 Mar 2017
Senner Christopher J. EVP and CFO
Sold, plan not stated
$250.80K 11,000 at 22.80
9.9%
3 Mar 2017
Haley Patrick J. Sr. Vice President, Commercial
Sold, plan not stated
$57.60K 2,500 at 23.04
2.3%
2 Mar 2017
POSTE GEORGE Director
Sold, plan not stated
$1.52M 67,400 at 22.58
46.5%
1 Mar 2017
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$998.55K 45,000 at 22.19
37.9%
1 Mar 2017
POSTE GEORGE Director
Sold, plan not stated
$196.29K 8,850 at 22.18
10.2%
1 Feb 2017
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.31M 70,000 at 18.65
48.7%
3 Jan 2017
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated 2×
$1.03M 70,000 at 14.65
48.7%
16 Dec 2016
FELDBAUM CARL B Director
Sold, plan not stated
$425.75K 25,000 at 17.03
33.9%
9 Dec 2016
Garber Alan M Director
Sold, plan not stated
$132.36K 7,832 at 16.90
11.3%
7 Dec 2016
SCANGOS GEORGE A Director
Sold, plan not stated
$3.15K 176 at 17.90
0.0%
5 Dec 2016
SCANGOS GEORGE A Director
Sold, plan not stated
$3.65M 204,718 at 17.81
12.3%
1 Dec 2016
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.17M 70,000 at 16.66
48.7%
Showing 351–400 of 404. ← Newer Page 8 of 9 Older →